扶正消瘤汤辅助细胞因子诱导杀伤细胞对晚期恶性肿瘤患者临床改善情况的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

2017年海南省卫生厅项目(16036030A2001)


Effects of Fuzheng Xiaoliu Decoction with CIK Cells on the Clinical Improvement in the Treatment of Patients with Advanced Malignant Tumor
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨扶正消瘤汤联合细胞因子诱导杀伤(CIK)细胞治疗对晚期恶性肿瘤患者的临床改善情况。方法:选取2016年1月至2017年6月广州中医药大学附属海南中医院收治的恶性肿瘤患者82例作为研究对象,随机分为对照组和观察组,每组41例。对照组给予CIK细胞过继免疫治疗,观察组在对照组的基础上联合扶正消瘤汤治疗。治疗1个月后,统计2组近期临床疗效,评估2组中医证候积分变化,比较2组免疫指标水平变化,观察治疗期间2组不良反应发生情况。结果:治疗后观察组总缓解率为6098%,显著高于对照组的3415%,差异有统计学意义(P<005);与治疗前比较,治疗后观察组中医证候积分均显著下降,且观察组显著低于对照组,差异有统计学意义(P<005);与治疗前比较,治疗后2组自然杀伤(NK)细胞、CD3+、CD4+T淋巴细胞比例和CD4+/CD8+比值均显著升高,观察组显著高于对照组,差异有统计学意义(P<005),2组CD8+T淋巴细胞比例明显降低,且观察组明显低于对照组,差异有统计学意义(P<005);治疗期间观察组总不良反应发生率为1707%,对照组总不良反应发生率为1951%,2组总不良反应发生率比较,差异无统计学意义(P>005)。结论:扶正消瘤汤联合CIK细胞治疗可明显提高晚期恶性肿瘤患者免疫功能,减轻其临床不适症状,疗效显著,安全可靠。

    Abstract:

    To explore the effects of Fuzheng Xiaoliu decoction with CIK cells on the clinical improvement in the treatment of patients with advanced malignant tumor.Methods:A total of 82 cases patients with advanced malignant tumor in Hainan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Traditional Chinese Medicine from January 2016 to June 2017 were selected and randomly divided into a control group and an observation group,with 41 cases in each group.The control group was treated with CIK cells adoptive immunotherapy,and the observation group was treated with Fuzheng Xiaoliu Decoction on the basis of the control group.One month after treatment,the recent clinical curative effect of 2 groups was statisticsed,and the TCM symptoms integral changes of the 2 groups were evaluated.The changes of immune index levels of 2 groups were compared,and the occurrence of adverse reactions of the 2 groups during the treatment was observed.Results:The total remission rate of the observation group was 6098%,which was significantly higher than 3415% of the control group (P<005); Compared with before treatment,the TCM symptoms integral of the observation group after treatment significantly declined,and the observation group was significantly lower than control group (P<005 or P<001); Compared with before treatment,the ratio of NK cells,T lymphocytes of CD3+,CD4+ and the ratio of CD4+/CD8+ significantly increased,and the observation group was significantly higher than the control group (P<005 or P<001).The CD8+ T lymphocytes levels of the 2 groups significantly reduced,and the observation group was significantly lower than the control group (P<005).The total incidence of adverse reactions in the observation group was 1707%,and the total incidence of adverse reactions in the control group was 1951%.There was no significant difference between the 2 groups (P>005).Conclusion:Fuzheng Xiaoliu Decoction with CIK cells can significantly improve the immune function of patients with advanced malignant tumors,reduce the clinical symptoms.The effect is significant,and it is safe and reliable.

    参考文献
    相似文献
    引证文献
引用本文

吴亭,邱晓堂,陈学武.扶正消瘤汤辅助细胞因子诱导杀伤细胞对晚期恶性肿瘤患者临床改善情况的影响[J].世界中医药,2019,(06).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2018-12-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-07-08
  • 出版日期:
文章二维码